New tricks for an old assay. by Clay, R
Innovations
Aworker accidentally spills an
industrial chemical on her bare
arm, a child splashes a household
cleaning liquid on his legs; how will their
skin react? If the product has the poten-
tial to induce an allergic response, one
reaction could be the redness and swelling
known as allergic contact dermatitis, a
sometimes serious occupational and con-
sumer health problem.
The chemicals in workplace and con-
sumer products sold worldwide must be
tested for their potential to cause such aller-
gic reactions. For decades, several guinea
pig tests have been used to identify human
contact allergens-the most common have
been the guinea pig maximization test
(GPMT) and the standard Buehler test.
Though accepted by the Organisation for
Economic Co-operation and Development
(OECD), which helps set industrial health
and safety guidelines for its 29 member
countries worldwide, both tests have limita-
tions: they use a large number of guinea
pigs, provide subjective rather than objec-
tive results, and are difficult to measure and
interpret when colored chemicals are evalu-
ated. Since the 1980s, investigators in the
United States and the United Kingdom
have sought an alternative test method that
would reduce the number of animals
required to test for dermal toxicity, and
refine the test process in order to circum-
vent those limitations.
"The requirements for a proposed new
test are that its performance has been ade-
quately assessed and the reproducibility [of
its results] demonstrated in different labo-
ratories around the world," says William
Stokes, associate director for animal and
alternative resources of the NIEHS's
Environmental Toxicology Program.
When a proposed alternative test
method seems relevant to federal testing
requirements, an independent scientific
peer review panel is put together to discuss
the proposed protocol and data, according
to Stokes. In September 1998, a peer
review panel brought together by the
Interagency Coordinating Committee on
the Validation of Alternative Methods
(ICCVAM) and the National Toxicology
Program's (NTP) Center for the Evaluation
of Alternative Toxicological Methods
began studying an alternative test method
to identify human contact allergens known
as the local lymph node assay (LLNA).
The LLNA has been used since the mid-
1980s as a screening test for skin sensitiza-
tion, but only positive results could be used
to make a regulatory decision. If the test
produced negative results, researchers were
required to perform a guinea pig test to vali-
date the results. The LLNA's supporters
hope it will now be accepted as a "stand-
alone" assay for testing the effects ofchemi-
cals on the skin. They argue that the LLNA
requires fewer animals than the other test
methods. "It could also cut the price oftest-
ing in half. And . . . testing time [is
reduced] from two months to one week,"
says Frank Gerberick, a principal scientist at
Procter & Gamble, one ofthree major labo-
ratories testing the LLNA (the other two are
Zeneca Central Toxicology Laboratory and
Unilever Research, both in the United
Kingdom). Says Gerberick, "We're not ask-
ing to replace the current methods; we just
want a little bit more ofa choice."
How the LLNAWorks
First conceived in 1984 by Ian Kimber,
head of research at the Zeneca Central
Toxicology Laboratory, the LLNA has been
the subject of numerous intra- and inter-
laboratory collaborations and published
papers. Whereas the guinea pig tests
observe an animal's skin reaction to a
chemical, the LLNA measures the response
ofthe lymph nodes to a substance.
Allergic contact dermatitis is a disease
mediated by lymphocytes, the central cell
type in the immune system. When suscep-
tible individuals are exposed to a chemical
allergen, those lymphocytes that are able
to recognize it as a foreign substance
divide and increase in number. It is this
increase in the number of chemical aller-
gen-responsive lymphocytes that renders
the individual sensitized; the stimulation
oflymphocyte division is, therefore, a cen-
tral event in contact allergy. Says Kimber,
"The potential of chemicals to cause skin
sensitization is measured as a function of
their ability to stimulate lymphocyte pro-
liferative responses in lymph nodes drain-
ing the site of exposure. So we reasoned
that measurement of this proliferative
activity might provide a sensitive endpoint
for the identification of those chemicals
that are able to cause sensitization."
Volume 106, Number 10, October 1998 * Environmental Health Perspectives A 488Innovations * LLNA: New Tricks for an Old Assay
The LLNA requires that a test chemical
be applied to the backs ofthe ears of4 or 5
young adult (6- to 16-week-old) female
mice. Each mouse is treated for 3 consecu-
tive days with varying concentrations ofthe
material, then rested for 2 days. On the
sixth day, the mice are euthanized and their
lymph nodes are excised and examined. A
test substance that causes a stimulation
index of three or greater, meaning a three-
fold proliferation oflymph node cells in the
test mice, at one or more concentrations is
considered to have skin sensitizing activity.
"Ifthe material is an allergen, it [will] stim-
ulate the immune system," says Gerberick.
"Ifyou have a chemical that's an allergen, it
stimulates the immune system so cells
divide, and that's whatwe're looking at."
In the GPMT, on the other hand, the
guinea pigs are injected with a chemical in
the shoulder region. After 6-8 days, sensiti-
zation is boosted by wearing a patch that
has been treated with the chemical over the
injected site for 48 hours. Twelve to 14
days later, another occluded patch is
attached to one flank for 24 hours. The two
sites are then scored for redness and
swelling after removal ofthe patches, at 48
and 24 hours, respectively.
The standard Buehler test requires 20
animals in the test group plus another 20
for control groups. Three 6-hour patches
are applied, one per week, to the same
shaved site. After a 2-week rest period, the
test animals and halfofthe control animals
receive another 6-hour patch at another
site. Then the test animals are tested again
7-15 days later. Reactions are graded
according to a five-point scale.
Most studies have compared LLNA test
results with those from the GPMT and the
Buehler test on the same batches ofchemi-
cals. Comparison with human data began
in 1991 and discussions with the Food and
Drug Administration (FDA) regarding reg-
ulatory review were initiated in 1996.
Results from some ofthe laboratories work-
ing with the FDA were published in 1998.
"In contrast to the other procedures, the
LLNA appears to offer increased efficiency,
less cost, and less time," says Stokes. "It's a
mechanistic test that looks at the prolifera-
tion oflymphocytes in the regional lymph
node. Counting the cells gives researchers a
more objective measurement, rather than
the subjective assessment of redness and
swelling on the skin. And, from an animal
welfare perspective, it requires fewer ani-
mals and [causes] less pain and distress."
Advantages and Limitations
As an alternative test method for allergic
contact dermatitis, supporters claim the
LLNA would also eliminate the need to
No worries. Approval of the local lymph node
assay as a stand-alone toxicity test for contact
dermatitis means that guinea pigs are no longer
required (as they were in standard allergenicity
tests).
boost the immune system response with an
adjuvant in guinea pig tests in order for the
response to be more easily measured.
Injected at the chemical site, the adjuvant
can cause local toxicity and unnecessary
trauma to the guinea pig. The adjuvant,
says Gerberick, "causes most ofthe discom-
fort in the guinea pigs, perhaps worse than
a booster shot. The LLNA does not require
an adjuvant."
In traditional guinea pig tests, allergic
activity is measured by observing the skin
for redness. This subjective method may
fail to adequately judge colored materials
that can obscure reddening ofthe skin sites.
Because the LLNA analyzes lymph node
activity rather than a topical skin reaction,
the color of a test material does not influ-
ence the test's performance.
The LLNA can also be used to evaluate
chemical relative potency. Potency mea-
surements are important when assessing the
likely risk of sensitization in humans.
Current guinea pig tests are by and large
unsuitable for use in potency assessments,
says Gerberick, because they are designed
only for hazard identification, not to ana-
lyze the response at different concentra-
tions, or potencies.
In the LLNA, it also is not necessary to
clip or shave the fur from the mice, as must
be done on several occasions during the
standard guinea pig tests. Says David
Basketter, a dermatotoxicologist at the
Safety and Environmental Assurance
Centre, part of Unilever Research, and an
LLNA investigator, "[This is a] minor
point, but it adds to the weight ofthe argu-
ment that the LLNA provides a consider-
able refinement in the way it minimizes the
chances for distress [to the animal]."
But the LLNA does have limitations.
Says Gerberick, "One question is whether it
is sensitive enough. The GPMT is a very
sensitive method because of its use of an
adjuvant. But we feel the LLNA is sensitive
enough to identifysignificant allergens."
The Next Step
As animal welfare advocates and the general
public express their concern over the treat-
ment of laboratory animals, researchers
have begun to seek more efficient and less
painful methods to test for the potential of
allergic contact dermatitis in humans. After
14 years of international trials, the LLNA
maysatisfy this need.
The NTP center's peer review panel
will draw conclusions on the usefulness
of the assay from its review of the test
method's protocol and data, says Stokes.
This conclusion will then be forwarded
through ICCVAM to federal regulatory
agencies, primarily the FDA, the EPA,
and the Occupational Safety and Health
Administration, which have the final say
on whether the LLNA will be incorporat-
ed into their testing regulations and
guidelines. The alternative test method
must also undergo the OECD process for
approval by its member countries in
order to achieve widespread international
acceptance.
Rebecca Clay
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